UFP Technologies, Inc. reported $632M of revenue over the trailing twelve months, +7.3% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $632M (to Q2 2026). Net income: $72M, trailing twelve months to Q2 2026. Free cash flow: $71M, trailing twelve months to Q4 2025. Operating margin: 15%, trailing twelve months to Q2 2026.

UFPTUFP Technologies, Inc.

Healthcare

$288.80+50% 1Y

$288.80

$185.2852 weeks$333.88

UFPT as reported

UFP Technologies, Inc. reported $632M of revenue over the trailing twelve months, +7.3% on the year before. 11 reported series are charted on this page, each one as filed.

$632M

Revenue, trailing twelve months · to Q2 2026 · +7.3% against the twelve months before

Net income: $72M
Net income · +7.7% year on year · trailing twelve months to Q2 2026
Free cash flow: $71M
Free cash flow · trailing twelve months to Q4 2025
Operating margin: 15%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for UFPT, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$632M	+7.3%	Q2 2026
Net income	$72M	+7.7%	Q2 2026
EPS	$9.28	+7.5%	Q2 2026
Gross margin	28%	n/a	Q2 2026
Operating margin	15%	n/a	Q2 2026
Net margin	11%	n/a	Q2 2026
ROE	16%	n/a	Q2 2026
ROA	10%	n/a	Q2 2026
ROIC	13%	n/a	Q2 2026
Free cash flow	$71M	n/a	Q4 2025
P/E	31.1	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.